Oncovir, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.oncovir.com
Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:3
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 2
1 (25.0%)Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Oncovir, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT04672291
- Locations
- 🇨🇦
Health Research Innovation Centre, Calgary, Alberta, Canada
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Phase 1
Completed
- Conditions
- Malignant Pleural Mesothelioma
- Interventions
- Biological: SafetyBiological: Expansion Cohort
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Oncovir, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT04525859
- Locations
- 🇺🇸
Icahn School of Medicine Mount Sinai, New York, New York, United States
Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1
Phase 1
Terminated
- Conditions
- Solid Cancer
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Oncovir, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT03721679
- Locations
- 🇺🇸
Chevy Chase RCCA, Chevy Chase, Maryland, United States
🇺🇸Bay Hematology Oncology, Easton, Maryland, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®
Phase 2
Completed
- Conditions
- SarcomaMelanomaHead and Neck CancerNon-Melanoma Skin Cancers
- First Posted Date
- 2015-04-22
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Oncovir, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT02423863
- Locations
- 🇺🇸
Chevy Chase RCCA, Chevy Chase, Maryland, United States
🇺🇸Dermatologic Surgery Center Washington DC, Chevy Chase, Maryland, United States
🇺🇸Bay Hematology Oncology, Easton, Maryland, United States
News
No news found